Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bloodloss”

12 trials

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00668031
What this trial is testing

Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement

Who this might be right for
Blood Loss, Surgical
Bayer 359
Large-scale testing (Phase 3)Study completedNCT01373359
What this trial is testing

Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin

Who this might be right for
Postpartum Hemorrhage
Jawaharlal Nehru Medical College 652
Large-scale testing (Phase 3)Ended earlyNCT00327379
What this trial is testing

Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery

Who this might be right for
Blood Loss, SurgicalPostoperative Hemorrhage
Bayer 54
Testing effectiveness (Phase 2)Study completedNCT00816023
What this trial is testing

A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume

Who this might be right for
BloodlossSurgical Procedures, Operative
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 276
Post-approval studies (Phase 4)UnknownNCT01444508
What this trial is testing

Effect of Colloid Versus Crystalloid on Coagulation

Who this might be right for
Bloodloss
K. C. Rasmussen 40
Testing effectiveness (Phase 2)Study completedNCT00888940
What this trial is testing

Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery

Who this might be right for
BloodlossSurgical Procedures, Operative
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 243
Not applicableStudy completedNCT02197780
What this trial is testing

Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD

Who this might be right for
Abdominal PainRectal BloodlossDiarrhea+4 more
University Medical Center Groningen 355
Not applicableStudy completedNCT06201910
What this trial is testing

Evaluation of Peripartum Blood Loss and Postpartum Anaemia in Macrosomia & Gemini

Who this might be right for
Bloodloss in Pregnancy
Goethe University 575
Post-approval studies (Phase 4)Study completedNCT00777166
What this trial is testing

Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia

Who this might be right for
Myocardial IschemiaHypotensionBloodloss
Uppsala University 103
Not applicableStudy completedNCT01306903
What this trial is testing

Minimal Extracorporeal Circuits (MECC) in Cardiac Surgery Procedures

Who this might be right for
Postoperative Bloodloss
Johann Wolfgang Goethe University Hospital 68
Testing effectiveness (Phase 2)Study completedNCT02041065
What this trial is testing

Waterjet Versus Ultrasound Dissection During Hepatic Transection

Who this might be right for
Liver Tumour
Karolinska University Hospital 84
Not applicableUnknownNCT00801190
What this trial is testing

This Study Will Compare the Effect of Starch Containing to Non-Starch Containing Intravenous Fluid on Blood Loss During Coronary Artery Bypass Graft Surgery

Who this might be right for
Bloodloss
St. Boniface Hospital 500

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation